NerivioInfinity FGD000100

GUDID 07290017578101

NerivioInfinity is a wireless remote electrical neuromodulation (REN) device for the acute and/or preventive treatment of migraine with or without aura in patients 12 years of age or older. This prescription device is self-applied to the upper arm and should be used in the home environment at the onset of migraine headache or aura. or every other day for preventive treatment. Nerivio utilizes an endogenous descending analgesic mechanism in which pain in one part of the body inhibits pain in multiple remote body regions (Conditioned Pain Modulation [CPM]). NerivioInfinity is a wireless wearable battery-operated device controlled by a mobile software application. The battery is rechargeable, and the electronic unit can be used up to 3 years. The electrodes are disposable and replaceable. A single electrode kit is sufficient for up to 18 treatments of 45 minutes each. The application has a graphical user interface (GUI) which includes graphical controls that the user can select using a touch screen. Activating the stimulation, controlling the stimulation intensity, monitoring the treatment duration, and pausing and terminating the stimulation are performed by this application. The application also provides notifications and indications on the connection state and the remaining number of treatments.

Theranica Bio-Electronics Ltd.

Craniofacial analgesia electrical stimulator Craniofacial analgesia electrical stimulator Craniofacial analgesia electrical stimulator Craniofacial analgesia electrical stimulator Craniofacial analgesia electrical stimulator Craniofacial analgesia electrical stimulator Craniofacial analgesia electrical stimulator Craniofacial analgesia electrical stimulator Craniofacial analgesia electrical stimulator Craniofacial analgesia electrical stimulator Craniofacial analgesia electrical stimulator Craniofacial analgesia electrical stimulator Craniofacial analgesia electrical stimulator Craniofacial analgesia electrical stimulator Craniofacial analgesia electrical stimulator Craniofacial analgesia electrical stimulator Craniofacial analgesia electrical stimulator
Primary Device ID07290017578101
NIH Device Record Key729df0be-7bc6-42ca-b296-2eb0049a785d
Commercial Distribution StatusIn Commercial Distribution
Brand NameNerivioInfinity
Version Model NumberFGD000100
Catalog NumberFGD000100
Company DUNS532352807
Company NameTheranica Bio-Electronics Ltd.
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusMR Unsafe
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usefalse
Lot Batchfalse
Serial Numbertrue
Manufacturing Datetrue
Expiration Datefalse
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Operating and Storage Conditions

Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal
Storage Environment TemperatureBetween 50 Degrees Fahrenheit and 80.6 Degrees Fahrenheit
Storage Environment HumidityBetween 40 Percent (%) Relative Humidity and 60 Percent (%) Relative Humidity
Storage Environment Atmospheric PressureBetween 70 KiloPascal and 106 KiloPascal

Device Identifiers

Device Issuing AgencyDevice ID
GS107290017578101 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

QGTDistal Transcutaneous Electrical Stimulator For Treatment Of Acute Migraine

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2023-11-28
Device Publish Date2023-11-20

Devices Manufactured by Theranica Bio-Electronics Ltd.

07290017578101 - NerivioInfinity2023-11-28NerivioInfinity is a wireless remote electrical neuromodulation (REN) device for the acute and/or preventive treatment of migraine with or without aura in patients 12 years of age or older. This prescription device is self-applied to the upper arm and should be used in the home environment at the onset of migraine headache or aura. or every other day for preventive treatment. Nerivio utilizes an endogenous descending analgesic mechanism in which pain in one part of the body inhibits pain in multiple remote body regions (Conditioned Pain Modulation [CPM]). NerivioInfinity is a wireless wearable battery-operated device controlled by a mobile software application. The battery is rechargeable, and the electronic unit can be used up to 3 years. The electrodes are disposable and replaceable. A single electrode kit is sufficient for up to 18 treatments of 45 minutes each. The application has a graphical user interface (GUI) which includes graphical controls that the user can select using a touch screen. Activating the stimulation, controlling the stimulation intensity, monitoring the treatment duration, and pausing and terminating the stimulation are performed by this application. The application also provides notifications and indications on the connection state and the remaining number of treatments.
07290017578101 - NerivioInfinity2023-11-28 NerivioInfinity is a wireless remote electrical neuromodulation (REN) device for the acute and/or preventive treatment of migrai
07290017578200 - NerivioInfinity Electrodes Kit2023-11-28 The NerivioInfinity Electrodes kit is a disposable and replaceable electrodes pad (one pair of electrodes) that connects to the
07290017578026 - Nerivio2022-01-18 Refill pack for Nerivio device
07290017578019 - Nerivio2019-09-18 Nerivio is a wireless remote electrical neuromodulation device for the acute treatment of migraine with or without aura in patie

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.